Supplementary Table S3 from Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition
收藏数据链接：
官方服务：
资源简介：
Supplementary Table S3. Pathway analysis of mRNA expression changes resulting from treatment of CML CD34+ cells with EZH2i (GSK343).
创建时间：
2016-11-01
